Get the Stockscreener App
0.9385
1.55%
-0.0148
After Hours:
.92
-0.0185
-1.97%
Cytosorbents Corp stock is traded at $0.9385, with a volume of 69,510.
It is down -1.55% in the last 24 hours and down -11.46% over the past month.
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
See More
Previous Close:
$0.9533
Open:
$0.9601
24h Volume:
69,510
Relative Volume:
0.39
Market Cap:
$58.90M
Revenue:
$33.79M
Net Income/Loss:
$-18.67M
P/E Ratio:
-2.62
EPS:
-0.3582
Net Cash Flow:
$-19.17M
1W Performance:
-2.81%
1M Performance:
-11.46%
6M Performance:
-12.29%
1Y Performance:
-11.46%
1-Day Range:
$0.92
$0.97
1-Week Range:
$0.92
$1.04
52-Week Range:
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
Name
Cytosorbents Corp
Sector
Industry
Phone
973-329-8885
Address
305 COLLEGE ROAD EAST, PRINCETON, NJ
Compare CTSO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.9385 | 59.33M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-23 | Initiated | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-17-20 | Initiated | Jefferies | Buy |
| Sep-01-20 | Initiated | SVB Leerink | Outperform |
| Aug-08-17 | Reiterated | Maxim Group | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| May-24-16 | Initiated | Maxim Group | Buy |
| Oct-29-15 | Upgrade | WBB Securities | Speculative Buy → Buy |
| May-12-15 | Reiterated | MLV & Co | Buy |
| Apr-01-15 | Reiterated | MLV & Co | Buy |
| Mar-05-15 | Initiated | MLV & Co | Buy |
| Feb-25-15 | Initiated | WBB Securities | Speculative Buy |
| Jan-27-15 | Reiterated | H.C. Wainwright | Buy |
View All
Cytosorbents Corp Stock (CTSO) Latest News
Using AI based signals to follow Cytosorbents CorporationJuly 2025 Outlook & Growth Focused Entry Reports - Newser
Has Cytosorbents Corporation formed a bullish divergenceTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Institutional scanner results for Cytosorbents CorporationMarket Activity Recap & Daily Technical Forecast Reports - Newser
Can swing trading help recover from Cytosorbents Corporation lossesWall Street Watch & Stock Portfolio Risk Control - Newser
Is Cytosorbents Corporation meeting your algorithmic filter criteriaQuarterly Profit Summary & Weekly Watchlist of Top Performers - Newser
Granahan Investment Management LLC Has $358,000 Position in Cytosorbents Corporation $CTSO - MarketBeat
What Fibonacci levels say about Cytosorbents Corporation reboundJuly 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
What’s the recovery path for long term holders of Cytosorbents Corporation2025 Valuation Update & AI Based Buy and Sell Signals - Newser
What’s next for Cytosorbents Corporation stock priceM&A Rumor & Daily Stock Trend Reports - Newser
Is Cytosorbents Corporation forming a reversal patternStop Loss & Safe Entry Momentum Tips - Newser
Earnings visualization tools for Cytosorbents CorporationQuarterly Trade Summary & Daily Entry Point Alerts - Newser
Developing predictive dashboards with Cytosorbents Corporation dataWeekly Trade Summary & Verified Short-Term Trading Plans - Newser
Tools to monitor Cytosorbents Corporation recovery probabilityWeekly Market Outlook & Weekly Stock Performance Updates - Newser
Is Cytosorbents Corporation stock reversal real or fakeMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
Technical signs of recovery in Cytosorbents CorporationWeekly Gains Summary & Smart Investment Allocation Tips - Newser
Risk vs reward if holding onto Cytosorbents Corporation2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Is Cytosorbents Corporation trending in predictive chart modelsInsider Selling & High Win Rate Trade Tips - Newser
Best data tools to analyze Cytosorbents Corporation stockMarket Movers & Long-Term Growth Plans - Newser
CytoSorbents at H.C. Wainwright: Strategic Growth and Regulatory Challenges - Investing.com
Will Cytosorbents Corporation rebound enough to break evenMarket Rally & Weekly Breakout Opportunity Watchlist - Newser
CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day - Ariva
International Experts Reveal Breakthrough Sepsis Treatment Results: CytoSorb's Impact on Patient Survival - Stock Titan
Momentum Screeners Rank Cytosorbents Corporation in Top 5 TodayJuly 2025 Analyst Calls & AI Driven Stock Movement Reports - beatles.ru
How to read the order book for Cytosorbents CorporationQuarterly Profit Review & Real-Time Stock Entry Alerts - Newser
Is now a turning point for Cytosorbents Corporation2025 Geopolitical Influence & Intraday High Probability Alerts - Newser
Combining machine learning predictions for Cytosorbents CorporationJuly 2025 Movers & Weekly Chart Analysis and Guides - Newser
Comparing Cytosorbents Corporation in custom built stock radarsEarnings Performance Report & Weekly Setup with High ROI Potential - Newser
Trend analysis for Cytosorbents Corporation this weekTrade Entry Report & High Accuracy Trade Alerts - Newser
Will Cytosorbents Corporation bounce back from current supportQuarterly Earnings Summary & High Yield Stock Recommendations - Newser
Historical volatility pattern of Cytosorbents Corporation visualizedDividend Hike & Consistent Income Trade Ideas - Newser
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference - PR Newswire
What drives Cytosorbents Corporation’s stock priceWeekly Stock Report & Weekly Top Gainers Trade List - خودرو بانک
Is Cytosorbents Corporation a defensive stockTrend Reversal & Target Return Focused Picks - خودرو بانک
Does Cytosorbents Corporation stock benefit from AI growthJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - خودرو بانک
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - ADVFN Brasil
What technical models suggest about Cytosorbents Corporation’s comeback2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
Is Cytosorbents Corporation stock entering bullish territoryMarket Growth Report & Daily Volume Surge Signals - Newser
How is Cytosorbents Corporation managing supply chain issuesJuly 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
Can trapped investors hope for a rebound in Cytosorbents CorporationWeekly Stock Analysis & AI Optimized Trading Strategy Guides - Newser
Cytosorbents Corp Stock (CTSO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):